Atlas Trials

Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer

Clinical trial NCT04608409 · COMPLETED

Trial details

NCT number
NCT04608409
Sponsor
Frederick R. Ueland, M.D.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2021-03-17
Primary completion
2024-05-17
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.